| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |